6533b7dafe1ef96bd126f689
RESEARCH PRODUCT
Untargeted Antifungal Treatment in Nonneutropenic Critically Ill Patients: Should Further Studies Be Performed Based on Trial Sequential Analysis Results?
Antonino GiarratanoAndrea Cortegianisubject
0301 basic medicineAntifungalmedicine.medical_specialtyAntifungal Agentsempirical treatmentmedicine.drug_classCritical Illness030106 microbiologyNetwork Meta-AnalysisAntifungal drug03 medical and health sciencesMedicineHumansPharmacology (medical)untargeted treatmentEconomics PharmaceuticalIntensive care medicineLetter to the EditorCandida spp.Pharmacologyantifungal drugCritically illbusiness.industryprophylaxiEmpirical treatmentInfectious DiseasesMycosesCandida sppbusinessyear | journal | country | edition | language |
---|---|---|---|---|
2018-07-01 |